Type IV collagen as a tumour marker for colorectal liver metastases
- 1 July 2011
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 37 (7) , 611-617
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Current management of colorectal hepatic metastasisExpert Review of Gastroenterology & Hepatology, 2009
- Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancerSurgical Oncology, 2009
- Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical useEuropean Journal of Cancer, 2007
- Arginase as a Useful Factor for the Diagnosis of Colorectal Cancer Liver MetastasesThe International Journal of Biological Markers, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- CEA, CA 242, CA 19-9, CA 72-4 and hCGβ in the Diagnosis of Recurrent Colorectal CancerTumor Biology, 2004
- Current treatment for colorectal cancer metastatic to the liverEuropean Journal of Surgical Oncology, 1999
- An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancerJAMA, 1993
- Comparison of four serum tumour markers in the diagnosis of colorectal carcinomaBritish Journal of Cancer, 1992
- Circulating CEA levels in patients with fulminant hepatitisDigestive Diseases and Sciences, 1982